(FEBRUARY 6, 2024) UVM Health Network President and CEO Sunny Eappen, M.D., M.B.A., and UVMHN Radiation Oncology Chair H. James Wallace, M.D., associate professor of radiology at the Larner College of Medicine, commented to the Press-Republican about a new initiative to upgrade cancer care services at network hospitals.

This semester, 28 first-year Larner College of Medicine students are learning about culinary medicine, which pairs nutritional science with preventative health care. Medical class of 2026 students Sarah Krumholz and Molly Hurd developed an extracurricular course that teaches classmates about lifestyle interventions for chronic disease.

Autoimmune disease is frequent in patients with myelodysplastic syndromes, but studies have been inconclusive about how the preexistence of autoimmunity affects survival in these patients. A new study by UVM Cancer Center member Diego Adrianzen Herrera, M.D. uses an epidemiologic analysis to clarify that issue.

A new collaboration between Vermont Medicaid and UVM Medical Center’s Comprehensive Pain Program allows Medicaid members with chronic pain to participate in complementary therapies including health coaching, massage, yoga, nutrition, acupuncture, and meditation. This pilot is an important step toward eliminating disparities in access to effective, integrative care for pain.

(OCTOBER 16, 2023) Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

To reduce barriers to skin cancer screening, the University of Vermont Cancer Center works with the UVM Cancer Center’s community advisory board member, Chief Donald Stevens, tribal leader for the Nulhegan Band of the Coosuk Abenaki Nation to bring skin checks out to communities in Vermont.

(OCTOBER 2, 2023) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, commented to WCAX about the annual Women’s Health and Cancer Conference held at UVM on September 29.

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.